Arvinas Holding Co. LLC

4 known investors

Arvinas is a clinical-stage biopharmaceutical company developing PROTAC protein degrader therapies for oncology and neurology. The company focuses on discovering and developing novel investigational drugs for patients with limited or ineffective treatment options.

Biotech